2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Homeostasis and transitional activation of regulatory T cells require c-Myc

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          c-Myc coordinates context-dependent homeostasis and transitional activation with metabolic programming of regulatory T cells.

          Abstract

          Regulatory T cell (T reg) activation and expansion occur during neonatal life and inflammation to establish immunosuppression, yet the mechanisms governing these events are incompletely understood. We report that the transcriptional regulator c-Myc (Myc) controls immune homeostasis through regulation of T reg accumulation and functional activation. Myc activity is enriched in T regs generated during neonatal life and responding to inflammation. Myc-deficient T regs show defects in accumulation and ability to transition to an activated state. Consequently, loss of Myc in T regs results in an early-onset autoimmune disorder accompanied by uncontrolled effector CD4 + and CD8 + T cell responses. Mechanistically, Myc regulates mitochondrial oxidative metabolism but is dispensable for fatty acid oxidation (FAO). Indeed, T reg-specific deletion of Cox10, which promotes oxidative phosphorylation, but not Cpt1a, the rate-limiting enzyme for FAO, results in impaired T reg function and maturation. Thus, Myc coordinates T reg accumulation, transitional activation, and metabolic programming to orchestrate immune homeostasis.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

          Activation of CD4+ T cells results in rapid proliferation and differentiation into effector and regulatory subsets. CD4+ effector T cell (Teff) (Th1 and Th17) and Treg subsets are metabolically distinct, yet the specific metabolic differences that modify T cell populations are uncertain. Here, we evaluated CD4+ T cell populations in murine models and determined that inflammatory Teffs maintain high expression of glycolytic genes and rely on high glycolytic rates, while Tregs are oxidative and require mitochondrial electron transport to proliferate, differentiate, and survive. Metabolic profiling revealed that pyruvate dehydrogenase (PDH) is a key bifurcation point between T cell glycolytic and oxidative metabolism. PDH function is inhibited by PDH kinases (PDHKs). PDHK1 was expressed in Th17 cells, but not Th1 cells, and at low levels in Tregs, and inhibition or knockdown of PDHK1 selectively suppressed Th17 cells and increased Tregs. This alteration in the CD4+ T cell populations was mediated in part through ROS, as N-acetyl cysteine (NAC) treatment restored Th17 cell generation. Moreover, inhibition of PDHK1 modulated immunity and protected animals against experimental autoimmune encephalomyelitis, decreasing Th17 cells and increasing Tregs. Together, these data show that CD4+ subsets utilize and require distinct metabolic programs that can be targeted to control specific T cell populations in autoimmune and inflammatory diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Fatty acid carbon is essential for dNTP synthesis in endothelial cells

            The metabolism of endothelial cells (ECs) during vessel sprouting remains poorly studied. Here, we report that endothelial loss of CPT1a, a rate-limiting enzyme of fatty acid oxidation (FAO), caused vascular sprouting defects due to impaired proliferation, not migration of ECs. Reduction of FAO in ECs did not cause energy depletion or disturb redox homeostasis, but impaired de novo nucleotide synthesis for DNA replication. Isotope labeling studies in control ECs showed that fatty acid carbons substantially replenished the Krebs cycle, and were incorporated into aspartate (a nucleotide precursor), uridine monophosphate (a precursor of pyrimidine nucleoside triphosphates) and DNA. CPT1a silencing reduced these processes and depleted EC stores of aspartate and deoxyribonucleoside triphosphates. Acetate (metabolized to acetyl-CoA, thereby substituting for the depleted FAO-derived acetyl-CoA) or a nucleoside mix rescued the phenotype of CPT1a-silenced ECs. Finally, CPT1 blockade inhibited pathological ocular angiogenesis, suggesting a novel strategy for blocking angiogenesis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Continuous requirement for the T cell receptor for regulatory T cell function

              Foxp3+ regulatory T cells (Treg cells) maintain immunological tolerance and their deficiency results in fatal multi-organ autoimmunity. Although heightened T cell receptor (TCR) signaling is critical for the differentiation of Treg cells, the role of TCR signaling in Treg cell function remains largely unknown. Here we demonstrate inducible ablation of the TCR results in Treg cell dysfunction which cannot be attributed to impaired Foxp3 expression, decreased expression of Treg cell signature genes or altered ability to sense and consume interleukin 2. Rather, TCR signaling was required for maintaining the expression of a limited subset of genes comprising 25% of the activated Treg cell transcriptional signature. Our results reveal a critical role for the TCR in Treg cell suppressor capacity.
                Bookmark

                Author and article information

                Journal
                Sci Adv
                Sci Adv
                SciAdv
                advances
                Science Advances
                American Association for the Advancement of Science
                2375-2548
                January 2020
                01 January 2020
                : 6
                : 1
                : eaaw6443
                Affiliations
                [1 ]Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA.
                [2 ]Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
                [3 ]Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA.
                [4 ]Hartwell Center for Bioinformatics and Biotechnology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA.
                [5 ]Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Center, Department of Oncology, University of Leuven, Leuven, Belgium.
                Author notes
                [*]

                Present address: Division of Rheumatology, Department of Medicine, and Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.

                []Corresponding author. Email: hongbo.chi@ 123456stjude.org
                Author information
                http://orcid.org/0000-0002-2691-501X
                http://orcid.org/0000-0002-9909-7732
                http://orcid.org/0000-0001-8232-7522
                http://orcid.org/0000-0003-4710-1776
                http://orcid.org/0000-0002-0834-7207
                http://orcid.org/0000-0003-0404-8522
                http://orcid.org/0000-0002-7535-0545
                http://orcid.org/0000-0003-3776-0858
                http://orcid.org/0000-0002-9997-2496
                Article
                aaw6443
                10.1126/sciadv.aaw6443
                6938709
                31911938
                653c8680-9854-404d-b1f9-c983f10c4020
                Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

                History
                : 11 January 2019
                : 01 November 2019
                Funding
                Funded by: doi http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: AI105887
                Funded by: doi http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: AI140761
                Funded by: doi http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: CA221290
                Funded by: doi http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: CA176624
                Categories
                Research Article
                Research Articles
                SciAdv r-articles
                Immunology
                Life Sciences
                Immunology
                Custom metadata
                Sef Rio

                Comments

                Comment on this article